SCHEDULES

SCHEDULE 1 Amendment of the Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of the Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

10.  In regulation 26 (insertion of Schedule 13 (transitional provisions in relation to EU Exit)), in the inserted Schedule 13—

(a) for “exit day” in each place it occurs substitute “IP completion day”;

(b) in paragraph 3—

(i) in the heading to the paragraph, after “medicinal products” insert “into Great Britain”;

(ii) in sub-paragraph (1), after “that is imported” insert “into Great Britain”.